Lorazepam
Product Images NDC 53002-7721

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 53002-7721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530027721)

Lorazepam 0.5 mg tablets packaging label from RPK Pharmaceuticals, Inc., NDC 53002-7721. The label includes prescribing instructions, directions to take tablets as directed by a prescriber, and sections for patient name, prescriber name, and clinic details. It states the product is a Schedule IV controlled substance and features 20 tablets per bottle.*

FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Chemical structure of Lorazepam, showing its molecular formula C15H10Cl2N2O2 and molecular weight of 321.16.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.